Navigation Links
NuView Life Sciences Awarded Grants Under the Patient Protection and Affordable Care Act of 2010
Date:11/4/2010

PARK CITY, Utah, Nov. 4, 2010 /PRNewswire/ -- NuView Life Sciences, Inc ("NuView"), a biopharmaceutical company specializing in the development of proprietary target specific biomarkers for utilization with Positron Emission Tomography ("PET") imaging procedures, announced today that its applications for the Qualifying Therapeutic Discovery Project Credit ("Therapeutic Credit") were approved.

The grants totaling just over $1.2 million dollars were awarded to NuView for further development and validation of several of the Company's projects. The diagnostic imaging biomarker projects that were approved under the Therapeutic Credit program are for breast cancer, lymphoma, cancer proliferation and cardiovascular imaging.

"We are very pleased that the underlying science of our pipeline candidates has been recognized under the Therapeutic Credit program, further enabling the clinical advancement of these projects," commented Paul Crowe, Chairman and Chief Executive Officer of NuView.

About the Qualifying Therapeutic Discovery ProjectThe Qualifying Therapeutic Discovery Project tax credit or grant is provided under new section 48D of the Internal Revenue Code (IRC), enacted as part of the Patient Protection and Affordable Care Act of 2010 (P.L. 111-148). The tax credit or grant is a benefit targeted to therapeutic discovery projects that show a reasonable potential to:

  • Result in new therapies to treat areas of unmet medical need or prevent, detect or treat chronic or acute diseases and conditions;
  • Reduce the long-term growth of health care costs in the United States, or significantly advance the goal of curing cancer within 30 years.

  • Allocation of the credit or grant also takes into consideration which projects show the greatest potential to create and sustain high-quality, high-paying U.S. jobs and to advance U.S. competitiveness in life, biological and medical sciences. The credit or grant is only available to companies with no more than 250 employees. The total amount of credits available to all companies is limited to $1 billion.

    About NuView Life Sciences, IncNuView Life Sciences, Inc is a privately held Utah based biopharmaceutical company developing target specific biomarkers for diagnostic Positron Emission Tomography ("PET") imaging procedures. The Company's clinical stage pipeline includes several proprietary products for diagnosing cancer and heart disease.  Please visit our website at www.nuviewinfo.com.For more information please contact:

    Rob Alday NuView Life Sciences, IncTel.  435-647-9758Fax. 435-647-5602info@nuviewinfo.com
    '/>"/>

    SOURCE NuView Life Sciences, Inc
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
    2. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
    3. Caliper Life Sciences and Sony DADC Collaborate to Develop Plastic Microfluidic Solutions
    4. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
    5. Pittsburgh Life Sciences Greenhouse and Innovation Works Announce Investments in Ib2C™
    6. Indiana Life Sciences Start Ups Garner More than $1.5 Million in Competitive Federal Funding
    7. Neurocrine Biosciences Reports Third Quarter 2010 Results
    8. Neurocrine Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
    9. Adeona CEO to Provide Keynote Address at the 2010 MichBio Expo & Conference Emerging Biosciences Showcase
    10. Caliper Life Sciences Signs Co-Marketing Pact with Illumina to Improve Sequencing Workflows
    11. Caliper Life Sciences Expands Offering for Next Generation Sequencing Workflows
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
    (Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
    (Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
    Breaking Medicine Technology:
    (Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
    (Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
    (Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
    (Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
    Breaking Medicine News(10 mins):